Clinical Trials Directory

Trials / Sponsors / Sirtris, a GSK Company

Sirtris, a GSK Company

Industry · 13 registered clinical trials.

StatusTrialPhaseStarted
CompletedA Study to Assess the Relative Bioavailability of New Oral Formulations of SRT2104 in Healthy Male Volunteers
Psoriasis
Phase 12012-10-30
CompletedA Phase 1b Study to Assess the Safety and Anti-inflammatory Effects of Two Different Doses of SRT2104 in Patie
Colitis, Ulcerative
Phase 12012-02-13
CompletedEffect of Multiple Dose Levels of SRT2379 on Endotoxin-Induced Inflammation
Sepsis
Phase 12011-08-30
CompletedA Study in Healthy Male Volunteers to Investigate Different Doses of a New Drug for the Treatment of Metabolic
Diabetes Mellitus, Type 2
Phase 12011-06-03
CompletedEffect of SRT2379 on Endotoxin-Induced Inflammation
Sepsis
Phase 12011-02-17
CompletedStudy of the Clinical Activity, Safety, and Tolerability of SRT2104 in Subjects With Moderate to Severe Plaque
Psoriasis
Phase 22010-06-07
CompletedA Clinical Trial to Assess the Safety of Oral SRT2104 and Its Effects on Vascular Dysfunction in Otherwise Hea
Diabetes Mellitus, Type 2
Phase 12010-05-28
CompletedClinical Study to Assess the Safety and Pharmacokinetics of SRT2104 in Type 2 Diabetic Human Subjects
Diabetes Mellitus, Type 2
Phase 22009-08-19
TerminatedA Clinical Study to Assess the Safety and Activity of SRT501 Alone or in Combination With Bortezomib in Patien
Multiple Myeloma
Phase 22009-03-30
CompletedA Clinical Study to Assess the Effect of Food and Gender on the Pharmacokinetics of SRT2104 Administered as an
Diabetes Mellitus, Type 2
Phase 12009-01-20
CompletedA Clinical Study to Evaluate the Pharmacokinetics and the Absolute Bioavailability of SRT2104 Given as a 250mg
Diabetes Mellitus, Type 2
Phase 12008-11-22
CompletedA Clinical Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of SRT501 in Subjects With Color
Neoplasms, Colorectal
Phase 12008-08-19
CompletedA Clinical Study to Assess the Safety and Pharmacokinetics of SRT2104 in Normal Healthy Male Volunteers
Diabetes Mellitus, Type 2, Healthy Volunteer
Phase 12008-05-01